These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31533277)

  • 1. Medical Outcomes in Women Who Became Pregnant after Vaccination with a Virus-Like Particle Experimental Vaccine against Influenza A (H1N1) 2009 Virus Tested during 2009 Pandemic Outbreak.
    Cérbulo-Vázquez A; Arriaga-Pizano L; Cruz-Cureño G; Boscó-Gárate I; Ferat-Osorio E; Pastelin-Palacios R; Figueroa-Damian R; Castro-Eguiluz D; Mancilla-Ramirez J; Isibasi A; López-Macías C
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31533277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.
    Valero-Pacheco N; Pérez-Toledo M; Villasís-Keever MÁ; Núñez-Valencia A; Boscó-Gárate I; Lozano-Dubernard B; Lara-Puente H; Espitia C; Alpuche-Aranda C; Bonifaz LC; Arriaga-Pizano L; Pastelin-Palacios R; Isibasi A; López-Macías C
    PLoS One; 2016; 11(2):e0150146. PubMed ID: 26919288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
    López-Macías C; Ferat-Osorio E; Tenorio-Calvo A; Isibasi A; Talavera J; Arteaga-Ruiz O; Arriaga-Pizano L; Hickman SP; Allende M; Lenhard K; Pincus S; Connolly K; Raghunandan R; Smith G; Glenn G
    Vaccine; 2011 Oct; 29(44):7826-34. PubMed ID: 21816199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seropositivity of influenza A H1NI in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic.
    Chao AS; Chang YL; Chao A; Wu TS; Yang LY; Lian R; Huang YC
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):37-40. PubMed ID: 28254223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.
    López-Macías C
    Hum Vaccin Immunother; 2012 Mar; 8(3):411-4. PubMed ID: 22330956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6-35 months: a randomized, double-blind, controlled phase I clinical trial.
    Li YP; Li W; Liang XF; Liu Y; Huang XC; Li CG; Li RC; Wang JZ; Wang HQ; Yin WD
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1297-307. PubMed ID: 23134570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.
    Helmig RB; Maimburg RD; Erikstrup C; Nielsen HS; Petersen OB; Nielsen LP; Hvidman L; Veirum JE; Henriksen TB; Storgaard M
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):833-9. PubMed ID: 25958884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
    Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lainé F; Jacqz-Aigrain E; Aboulker JP; Launay O;
    Ann Intern Med; 2011 Dec; 155(11):733-41. PubMed ID: 22147712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
    PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.
    Fabiani M; Bella A; Rota MC; Clagnan E; Gallo T; D'Amato M; Pezzotti P; Ferrara L; Demicheli V; Martinelli D; Prato R; Rizzo C
    Vaccine; 2015 May; 33(19):2240-2247. PubMed ID: 25820060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of influenza A H1N1 and seroconversion of mothers and infants induced by a single dose of monovalent vaccine.
    Chao A; Huang YC; Chang YL; Wang TH; Chang SD; Wu TS; Wu TL; Chao AS
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):356-9. PubMed ID: 24075373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study.
    Tavares F; Nazareth I; Monegal JS; Kolte I; Verstraeten T; Bauchau V
    Vaccine; 2011 Aug; 29(37):6358-65. PubMed ID: 21596080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Krause TG; Emborg HD; Melbye M; Hviid A
    JAMA; 2012 Jul; 308(2):165-74. PubMed ID: 22782418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.
    Sammon CJ; McGrogan A; Snowball J; de Vries CS
    Hum Vaccin Immunother; 2013 Apr; 9(4):917-23. PubMed ID: 23364304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination.
    Baum U; Leino T; Gissler M; Kilpi T; Jokinen J
    Vaccine; 2015 Sep; 33(38):4850-7. PubMed ID: 26238723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study.
    Launay O; Krivine A; Charlier C; Truster V; Tsatsaris V; Lepercq J; Ville Y; Avenell C; Andrieu T; Rozenberg F; Artiguebielle F; Tréluyer JM; Goffinet F;
    PLoS One; 2012; 7(12):e52303. PubMed ID: 23300637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.
    Conlin AMS; Bukowinski AT; Levine JA; Khodr ZG; Kaur N; Farrish SC; Sevick CJ
    Vaccine; 2018 May; 36(20):2855-2860. PubMed ID: 29625766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth.
    Richards JL; Hansen C; Bredfeldt C; Bednarczyk RA; Steinhoff MC; Adjaye-Gbewonyo D; Ault K; Gallagher M; Orenstein W; Davis RL; Omer SB
    Clin Infect Dis; 2013 May; 56(9):1216-22. PubMed ID: 23378281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.